Publications

Imeglimin

The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells

Vial, G., et al. Endocrinol Diabetes Metab — 2021

Mechanism of Action of Imeglimin: A Novel Therapeutic Agent for Type 2 Diabetes

Hallakou-Bozec, S., et al. Diabetes Obes Metab — 2021

Imeglimin Preserves Islet β-cell Mass in Type 2 Diabetic ZDF Rats

Hallakou-Bozec, S., et al. Endocrinol Diabetes Metab — 2020

Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of Type 2 Diabetes

Fouqueray, P., et al. Journal of Diabetes & Metabolism — 2011

PXL065